Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysis

Anouk E. J. Latenstein, Tara M. Mackay, Geert-Jan Creemers, Casper H. J. van Eijck, Jan Willem B. de Groot, Nadia Haj Mohammad, Marjolein Y. V. Homs, Hanneke W. M. van Laarhoven, I. Quintus Molenaar, Bert-Jan ten Tije, Judith de Vos-Geelen, Marc G. Besselink, Lydia G. M. van der Geest, Johanna W. Wilmink*, Dutch Pancreatic Canc Grp

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)705-712
Number of pages8
JournalActa Oncologica
Volume59
Issue number6
DOIs
Publication statusPublished - 2 Jun 2020

Keywords

  • LONG-TERM SURVIVAL
  • CANCER
  • GEMCITABINE
  • RESECTION
  • PATTERNS
  • CENTRALIZATION
  • FOLFIRINOX
  • BENEFIT

Cite this

Latenstein, A. E. J., Mackay, T. M., Creemers, G-J., van Eijck, C. H. J., de Groot, J. W. B., Haj Mohammad, N., Homs, M. Y. V., van Laarhoven, H. W. M., Molenaar, I. Q., ten Tije, B-J., de Vos-Geelen, J., Besselink, M. G., van der Geest, L. G. M., Wilmink, J. W., & Dutch Pancreatic Canc Grp (2020). Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysis. Acta Oncologica, 59(6), 705-712. https://doi.org/10.1080/0284186X.2020.1725241